FIBROGEN INC - Common Stock, $0.01 par value (FGEN)

Historical Holders from Q4 2014 to Q2 2025

Symbol
FGEN on Nasdaq
CUSIP
31572Q808
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
101M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
15K
Holdings value
$79.5K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
1
Number of buys
1
Number of sells
-51
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of FIBROGEN INC - Common Stock, $0.01 par value (FGEN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 8.42% +23.9% $2.21M $442K 8.5M +25% Armistice Capital, LLC Mar 31, 2025
PRIMECAP MANAGEMENT CO/CA/ 4.58% $1.2M 4.62M PRIMECAP MANAGEMENT CO/CA/ Dec 31, 2024

Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 15K $79.5K -$10.1M $5.30 1
2025 Q1 33M $10.2M -$1.81M $0.31 52
2024 Q4 36.2M $19.2M -$4.58M $0.53 64
2024 Q3 45.9M $18.9M -$6.43M $0.40 68
2024 Q2 56.5M $50.4M -$9.05M $0.89 102
2024 Q1 61.2M $144M -$17.8M $2.35 108
2023 Q4 230K $204K +$181K $0.89 2
2023 Q3 68.3M $58.9M -$24.6M $0.86 105
2023 Q2 75.6M $204M -$173M $2.70 148
2023 Q1 76.4M $1.42B +$29.3M $18.66 170
2022 Q4 74.8M $1.2B +$35.3M $16.02 141
2022 Q3 72.1M $939M +$36.2M $13.01 142
2022 Q2 70.7M $747M +$27.8M $10.56 142
2022 Q1 67.9M $817M +$18.2M $12.02 148
2021 Q4 66.2M $933M +$30.9M $14.10 153
2021 Q3 64M $653M -$172M $10.22 153
2021 Q2 67.7M $1.8B -$93.7M $26.63 171
2021 Q1 71.1M $2.47B -$16.2M $34.71 191
2020 Q4 71.5M $2.65B +$82.7M $37.09 199
2020 Q3 68.8M $2.83B +$68.9M $41.12 203
2020 Q2 67.2M $2.72B +$110M $40.53 186
2020 Q1 62.6M $2.17B +$118M $34.75 178
2019 Q4 61.3M $2.63B +$37.7M $42.89 205
2019 Q3 60.1M $2.22B -$20.1M $36.98 200
2019 Q2 61.2M $2.76B +$192M $45.18 184
2019 Q1 57.8M $3.14B +$64M $54.35 216
2018 Q4 56.5M $2.62B -$105M $46.28 189
2018 Q3 55.9M $3.39B -$20.7M $60.75 181
2018 Q2 55.5M $3.47B +$230M $62.60 187
2018 Q1 53.3M $2.46B +$131M $46.20 188
2017 Q4 50.2M $2.38B +$105M $47.40 182
2017 Q3 47.8M $2.57B +$545M $53.80 175
2017 Q2 37.8M $1.22B +$274M $32.30 144
2017 Q1 30.9M $761M +$114M $24.65 137
2016 Q4 30.1M $645M +$2.9M $21.40 134
2016 Q3 30.8M $637M -$11.9M $20.70 130
2016 Q2 31.6M $518M -$37.2M $16.41 142
2016 Q1 32.6M $694M +$21.8M $21.29 132
2015 Q4 31.3M $953M +$95.7M $30.47 132
2015 Q3 28.4M $623M +$68.1M $21.92 115
2015 Q2 24.1M $566M +$212M $23.50 92
2015 Q1 14.3M $448M +$11.9M $31.38 73
2014 Q4 14.8M $400M +$389M $27.34 65